Vimarsana
Biggest News Aggregation in the World

Page 2 - Thomas Eldered News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Thomas Eldered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Thomas Eldered Today - Breaking & Trending Today

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie - Vimarsana News

Mendus AB: Mendus and NorthX Biologics to enter into strategic cell therapy manufacturing alliance supported by new investor Flerie

Mendus AB , a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announces that it has entered into a manufacturing alliance with NorthX Biologics AB . NorthX is a... | June 8, 2023

Amarna Therapeutics announces appointment of Dr Henk Streefkerk as new CEO - Vimarsana News

Amarna Therapeutics announces appointment of Dr Henk Streefkerk as new CEO

/PRNewswire/ -- Amarna Therapeutics, a privately-held biotechnology company developing transformative gene therapies in a range of rare and prevalent diseases,...

Announcement from the 2023 Annual General Meeting of Toleranzia AB (publ) - Vimarsana News

Announcement from the 2023 Annual General Meeting of Toleranzia AB (publ)

The Annual General Meeting of Toleranzia AB , 556877-2866, took place today, 7 June 2023. The meeting was conducted with physical participation and by postal voting in accordance with § 9 of the... | June 7, 2023

Communiqué from the Annual General Meeting of Xintela AB (publ) - Vimarsana News

Communiqué from the Annual General Meeting of Xintela AB (publ)

Today, Friday 12 May 2023, the Annual General Meeting was held in Xintela AB . The following main decisions were made. The decisions were taken unanimously. Profit allocation and decision on discharge... | May 12, 2023

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform - Vimarsana News

Prokarium Announces $30 Million Financing to Deliver Lead Program into Clinic and Build Novel Therapeutic Platform

Prokarium's mission is to re-engineer evolution into a synthetic biology platform for novel immunotherapies Proceeds will support clinical development of the Company's lead oncology candidate